Global Policy Forum

Brazil to Ignore Patent on AIDS Drug

Print
Washington Post
August 23, 2001

The Brazilian government said on Tuesday that it will declare AIDS a "national emergency," triggering a law that will allow domestic production of a cheaper, generic version of a patented and costly AIDS drug, reports the Washington Post (A20). Health Minister Jose Serra said in a telephone interview from Brasilia that the government made the decision after its negotiations to lower the price of nelfinavir, and AIDS drug now made by Hoffman-La Roche Inc. and marketed in conjunction with the U.S.-base Pfizer, broke down two weeks ago. Companies that make AIDS drugs have been criticized by developing nations with high rates of AIDS for not making the price of treatment affordable.


Although India, South Africa and other nations are also developing generic AIDS drugs, Brazil is emerging as the world leader in the crusade to break down what Serra called "the AIDS monopolies " held by large, foreign pharmaceutical companies.

Serra said he had begun the process of issuing a license to produce nelfinavir, reports the New York Times (C6). If Brazil goes through with its threat to issue what is often called a compulsory license, it would be the first time that the government of a poor country has decided to allow generic copies of a brand-name drug to be made without the permission of the company that owns the patent.


More Information on Health, Poverty and Development

FAIR USE NOTICE: This page contains copyrighted material the use of which has not been specifically authorized by the copyright owner. Global Policy Forum distributes this material without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. We believe this constitutes a fair use of any such copyrighted material as provided for in 17 U.S.C § 107. If you wish to use copyrighted material from this site for purposes of your own that go beyond fair use, you must obtain permission from the copyright owner.


 

FAIR USE NOTICE: This page contains copyrighted material the use of which has not been specifically authorized by the copyright owner. Global Policy Forum distributes this material without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. We believe this constitutes a fair use of any such copyrighted material as provided for in 17 U.S.C § 107. If you wish to use copyrighted material from this site for purposes of your own that go beyond fair use, you must obtain permission from the copyright owner.